Waldencast plc (WALD)

USD 3.53

(-9.49%)

Market Cap (In USD)

395.65 Million

Revenue (In USD)

218.13 Million

Net Income (In USD)

-89.98 Million

Avg. Volume

270.98 Thousand

Currency
USD
Country
Technology
Open
-
Prev. Close
-
Day Range
-
Year Range
2.405-11.72
PE
-
EPS
-
Beta Value
-0.53
ISIN
JE00BPG99318
CUSIP
G9503X103
CIK
1840199
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Technology
Industry
Software - Application
CEO
Mr. Michel Brousset
Employee Count
-
Website
http://www.waldencast.com
Ipo Date
2021-05-12
Details
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.